Glenmark PharmaceuticalsGMKPF
13F holders, Q1 2024 (March 31)1holders
$11.48avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Glenmark Pharmaceuticals Ltd. (GMKPF) in their 13F filings. The largest holder was Stanley-Laman Group, Ltd. ($1.7M).
- Company
- Glenmark Pharmaceuticals Ltd.
- CUSIP
- Y2711C144
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Stanley-Laman Group, Ltd. | 0.22% | Reduce -28.6% | 150,000 | $1.7M |
"% of holder's portfolio" is GMKPF's weight in each manager's 13F, not the share of Glenmark Pharmaceuticals Ltd. the manager owns.